Kitadate, A., Kobayashi, H., Abe, Y., Narita, K., Miura, D., Takeuchi, M. and Matsue, K. (2020) “Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients”, Haematologica. Pavia, Italy, 105(1), pp. e37-e40. doi: 10.3324/haematol.2019.219683.